Filing Details
- Accession Number:
- 0001618921-22-000098
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-11-22 20:20:54
- Reporting Period:
- 2022-11-18
- Accepted Time:
- 2022-11-22 20:20:54
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1618921 | Walgreens Boots Alliance Inc. | WBA | Retail-Drug Stores And Proprietary Stores (5912) | 471758322 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1947552 | M. Kevin Ban | C/O Walgreens Boots Alliance, Inc. 108 Wilmot Road Deerfield IL 60015 | Evp, Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2022-11-18 | 10,303 | $34.04 | 38,219 | No | 4 | M | Direct | |
Common Stock | Disposition | 2022-11-18 | 10,303 | $40.19 | 27,916 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Employee Stock Option (Right to Buy) | Disposition | 2022-11-18 | 10,303 | $0.00 | 10,303 | $34.04 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
5,167 | 2030-11-01 | No | 4 | M | Direct |
Footnotes
- Includes shares underlying restricted stock units issued in lieu of dividends (through November 15, 2022) on outstanding restricted stock units.
- The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.19 to $40.22, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer, or any securityholder of the issuer, upon request, information regarding the number of shares sold at each price within the range indicated.
- The option, representing a right to purchase a total of 15,470 shares, became exercisable with respect to 5,151 shares on November 1, 2021, and with respect to 5,152 shares on November 1, 2022.